Measurement of molecular biomarkers to predict tumor response in estrogen receptor positive breast cancer after dose-dense (biweekly) paclitaxel/carboplatin neoadjuvant chemotherapy

Tumor Response ◽

Molecular Biomarkers ◽

Dose Dense ◽

Measurement of molecular biomarkers that predict the tumor response in estrogen receptor-positive breast cancers after dose-dense (biweekly) paclitaxel/carboplatin neoadjuvant chemotherapy

Oncotarget ◽

10.18632/oncotarget.19686 ◽

2017 ◽

Vol 8 (60) ◽

pp. 101087-101094 ◽

Cited By ~ 1

Author(s):

Teng Zhu ◽

Fangping Xu ◽

Liulu Zhang ◽

Yifang Zhang ◽

Ciqiu Yang ◽

...

Keyword(s):

Estrogen Receptor ◽

Tumor Response ◽

Molecular Biomarkers ◽

Breast Cancers ◽

Dose Dense

Estrogen receptor positive breast cancer identified by 95-gene classifier as at high risk for relapse shows better response to neoadjuvant chemotherapy

Cancer Letters ◽

10.1016/j.canlet.2012.04.017 ◽

2012 ◽

Vol 324 (1) ◽

pp. 42-47 ◽

Cited By ~ 6

Author(s):

Ryo Tsunashima ◽

Yasuto Naoi ◽

Kazuki Kishi ◽

Yosuke Baba ◽

Atsushi Shimomura ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Response To Neoadjuvant Chemotherapy ◽

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer

Frontiers in Oncology ◽

10.3389/fonc.2013.00317 ◽

2013 ◽

Vol 3 ◽

Cited By ~ 2

Author(s):

David M. Marcus ◽

Jeffrey M. Switchenko ◽

Roshan Prabhu ◽

Ruth O’Regan ◽

Amelia Zelnak ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Hormonal Therapy ◽

Neoadjuvant Hormonal Therapy ◽

Menopausal Women ◽

Post Menopausal ◽

Neoadjuvant chemotherapy with or without the concurrent hormone therapy that has downregulated estrogen level in estrogen receptor positive breast cancer: NACED randomized multicenter phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e11501 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e11501-e11501 ◽

Cited By ~ 1

Author(s):

Naoki Watanabe ◽

Takayuki Iwamoto ◽

Takayuki Motoki ◽

Kumi Sugiu ◽

Masako Omori ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Hormone Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Estrogen Level ◽

Multicenter Phase ◽

Th2 cell infiltrations predict neoadjuvant chemotherapy response of estrogen receptor-positive breast cancer

Gland Surgery ◽

10.21037/gs-20-571 ◽

2021 ◽

Vol 10 (1) ◽

pp. 154-165

Author(s):

Lan Le ◽

Yoshihisa Tokumaru ◽

Masanori Oshi ◽

Mariko Asaoka ◽

Li Yan ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Chemotherapy Response ◽

Th2 Cell ◽

Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e11506 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e11506-e11506

Author(s):

Halle C. F. Moore ◽

Baidehi Maiti ◽

Lisa A. Rybicki ◽

Christine Booth ◽

Jame Abraham ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Predictors Of Response ◽

Response To Neoadjuvant Chemotherapy ◽

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

OncoTargets and Therapy ◽

10.2147/ott.s10155 ◽

2010 ◽

pp. 1 ◽

Cited By ~ 4

Author(s):

Sherene Loi ◽

Criscitiello ◽

Fumagalli ◽

Saini

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Patient Selection ◽

Early Stage ◽

Molecular Biomarkers ◽

Clinical Use ◽

FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer

Breast Cancer ◽

10.1007/s12282-013-0482-2 ◽

2013 ◽

Vol 22 (3) ◽

pp. 308-316 ◽

Cited By ~ 11

Author(s):

Mai Kawase ◽

Tatsuya Toyama ◽

Satoru Takahashi ◽

Shinya Sato ◽

Nobuyasu Yoshimoto ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Prognostic Marker ◽

Foxa1 Expression ◽

Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor‐positive breast cancer patients

Journal of Surgical Oncology ◽

10.1002/jso.26096 ◽

2020 ◽

Author(s):

Michael R. Boland ◽

Éanna J. Ryan ◽

Timothy Nugent ◽

Darina Gilroy ◽

Michael E. Kelly ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Progesterone Receptor ◽

Cancer Patients ◽

Progesterone Receptor Status ◽

Breast Cancer Patients ◽

Response To Neoadjuvant Chemotherapy ◽

Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-19-1872 ◽

2020 ◽

Vol 26 (15) ◽

pp. 4120-4134 ◽

Cited By ~ 8

Author(s):

James R. Whittle ◽

François Vaillant ◽

Elliot Surgenor ◽

Antonia N. Policheni ◽

Göknur Giner ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Tumor Response ◽

Dual Targeting ◽